Skip Navigation

Cardiovascular Research 1999 41(3):754-764; doi:10.1016/S0008-6363(98)00249-1
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bhagat, K.
Right arrow Articles by Vallance, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhagat, K.
Right arrow Articles by Vallance, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS

Kiran Bhagata,1, Aroon D Hingoranila, Miriam Palaciosb, Ian G Charlesb and Patrick Vallancea,*

aCentre for Clinical Pharmacology & Therapeutics, Wolfson Institute for Biomedical Research, University College London, 5 University St, London WC1E 6JJ, UK
bMolecular Biology Laboratory, Wolfson Institute for Biomedical Research, University College London, 5 University St, London WC1E 6JJ, UK

* Corresponding author. Tel.: +44-171-209-6351; Fax: +44-171-813-2846; E-mail: patrick.vallance@ucl.ac.uk

Objective: Venodilatation is a feature of endotoxaemia and sepsis. We have tested directly the hypothesis that three cytokines (IL-1β, TNF{alpha} and IL-6) generated during endotoxaemia affect venous tone in humans in vivo by increasing NO generation and explored whether the NO comes from the iNOS or eNOS isoform. Design and intervention: Cytokines were given into a superficial vein in very low doses sufficient only to produce changes in the study vessel. The effects of cytokines on the response to noradrenaline were examined. Results: IL-1β increased basal NO-induced dilatation in the study vein, and this was sufficient to attenuate the constrictor response to exogenous noradrenaline or sympathetic stimulation. The effects were maximal at 6 h and both NG-monomethyl-L-arginine and aminoguanidine caused significant reversal of the IL-1β effects. However, no induction of iNOS mRNA was detected in the tissue samples. Instead, mRNA encoding eNOS and GTP cyclohydrolase-1 was detected in all vessels. Conclusion: The simplest explanation of these results is that IL-1β induces expression of GTP cyclohydrolase-1 which leads to increased generation of BH4 and activation of eNOS. This study identifies IL-1β as a key cytokine causing physiologically significant venodilatation in humans by increasing NO generation and suggests that this can occur even in the absence of iNOS expression.

KEYWORDS Nitric oxide; Veins; Septic shock; GTP cyclohydrolase 1; Human; Cytokines; Tetrahydrobiopterin; Inducible nitric oxide synthase

1 These authors contributed equally to this work and should be considered as joint first authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.